drugset / Trial / NCT04731974

Acute Concussion and Melatonin

NCT04731974

Phase 2 Unknown 254 enrolled Children's National Research Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, the investigator plans a randomized trial of melatonin versus placebo post acute pediatric concussion. The investigator hypothesizes that patients with acute concussions managed with melatonin will have improved sleep, decreased depressive symptoms, decreased risk of prolonged concussion symptoms and faster resolution of concussion symptoms.

Timeline

Start
2023-03-01
Primary completion
2024-06-30
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 3 mg Oral